RIGL
RigelBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RIGL vs peer average
67/100
RIGL vs. peer average (B vs. C)
Grade spread
A 3 · B 2 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AQST is the first available peer comparator.
Aquestive is a useful small-cap specialty pharma peer because both names balance commercial revenue with pipeline optionality, although AQST is more development-heavy and has less current marketed-product support than Rigel.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RIGL
Rigel
AQST
Aquestive Therapeutics
Grade
B
F
Momentum
90
10
Value
71
41
Sentiment
22
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AQST
RIGL / AQST
Grade Position
In line
RIGL vs. peer average (B vs. C)
67/100
Momentum
90
RIGLValue
71
RIGLSentiment
22
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RIGL
AQST is the first peer returned for this comparison set.